ReviewJournal of translational medicine2026

Deep learning-driven prediction of on-target activity, off-target risk, and repair outcomes in CRISPR/Cas9: current landscape and multi-scale perspectives.

Weian Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.